10x Genomics Inc - Ordinary Shares - Class A
TXG
Market Cap$2.79B
Close$
$42.06
59.4% upside
Current Fair Value
59.4% upsideUndervalued by 59.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.79 Billion |
|---|---|
| Enterprise Value | $2.42 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.24 |
| Beta | 2.13 |
| Outstanding Shares | 105,651,593 |
| Avg 30 Day Volume | 2,131,010 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.55 |
|---|---|
| PEG | -58.18 |
| Price to Sales | 5.28 |
| Price to Book Ratio | 4.4 |
| Enterprise Value to Revenue | 3.86 |
| Enterprise Value to EBIT | -11.3 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About 10x Genomics Inc
CEO: Serge Saxonov